Microsaic Systems Appoint Sales and Marketing Manager
News Aug 08, 2011
Samantha joins Microsaic Systems from Uniqsis Ltd where she successfully launched and grew sales of innovative solutions to customers from the pharmaceutical industry across the USA and Europe.
Microsaic is the first and only company to have successfully miniaturised mass spectrometry (“MS”) through the development of its patented chip-based technologies (ionchip®, spraychip® and vac-chip®). The Company’s first product, the Microsaic 3500 MiD®, was launched in January 2011. It is a desktop MS system that is smaller, lighter, more energy efficient and cheaper to run than legacy conventional MS systems.
Mass spectrometry is widely accepted as a ‘gold-standard’ method for identifying chemicals. As a result, this technique is used routinely by chemists across a range of sectors including government, energy, utilities, pharmaceuticals, environmental, food and drink, healthcare and industrial chemicals.
Commenting on today’s appointment, Alan Finlay, Chief Executive of Microsaic Systems plc, said:
"We are delighted to welcome Samantha to the team. These past months have seen Microsaic Systems make good commercial and technical progress including successful product demonstrations to end-users from a broad range of markets, a growing number of engagements with sales channels and OEM partners and a resounding reception for our products and technology at ASMS 2011, the premier trade fair for our industry. In her role, Samantha will be capitalising on the interest generated so far to accelerate product introduction.”
By leveraging an organ-on-a-chip model and a bioreactor, four human gut metabolites have been identified that can help explain the enhanced sensitivity of the human colon towards enterohemorrhagic E. coli, which is responsible for more than 100,000 infections per year in the USA alone.READ MORE
A skin swab test for Parkinson's has become a real possibility, after mass spectrometry was used to detect altered levels of specific compounds on the skin of people with the condition. The research is a result of the incredible ability of one woman to detect a unique odor on the skin of people with Parkinson's disease. These findings open the door to a non-invasive screening test.READ MORE